Literature DB >> 15510056

Auto-titrating continuous positive airway pressure for treating adult patients with sleep apnea syndrome.

M-P d'Ortho1.   

Abstract

PURPOSE OF REVIEW: The treatment of sleep apnea syndrome (SAS) is continuous positive airway pressure (CPAP) as the first line of therapy. The current standard is for an attendant technician to titrate CPAP by means of an in-laboratory polysomnography to obtain a fixed single pressure. Over the past decade and a half, some devices able to modify the pressure delivered to the patient overnight and from night to night have become available. The efficacy of such devices to manage SAS has been demonstrated, however the question of their use either as unattended APAP to determine pressures for fixed CPAP or for self-adjusting APAP treatment on a long-term basis is still matter of debate. RECENT
FINDINGS: However, if cost considerations may render reluctant to APAP, off note, using APAP could allow initiation of treatment more quickly, reduce in-laboratory time, and reduce healthcare costs.
SUMMARY: Auto-titrating continuous positive airway pressure and CPAP are to date equivalent in terms of efficacy to treat SAS, but APAP could allow quick initiation of treatment and therefore reduce healthcare costs.

Entities:  

Mesh:

Year:  2004        PMID: 15510056     DOI: 10.1097/01.mcp.0000144438.73152.4a

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  2 in total

1.  Autotitration positive airway pressure therapy in patients with obstructive sleep apnea who are intolerant of fixed continuous positive airway pressure.

Authors:  James M Parish; Bernie W Miller; Joseph G Hentz
Journal:  Sleep Breath       Date:  2007-11-28       Impact factor: 2.816

2.  Combination of obstructive sleep apnoea and insomnia treated by continuous positive airway pressure with the SensAwake pressure relief technology to assist sleep: a randomised cross-over trial protocol.

Authors:  Jean Louis Pepin; Frédéric Gagnadoux; Alison Foote; Rachel Vicars; Bhavi Ogra; Véronique Viot-Blanc; Meriem Benmerad; Marie-Pia D'Ortho; Renaud Tamisier
Journal:  BMJ Open       Date:  2017-10-27       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.